MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Expiratory strength in Parkinson’s disease patients? Does time matter?

    R. Guimaraes, F. Cendes, L. Paiva, MF. Satollo, M. Diogo, L. Durans (Campinas, Brazil)

    Objective: To assess the effectiveness of cough in Parkinson’s Disease (PD) patients in mild, moderate and severe disease stages. Background: Parkinson's Disease is the second…
  • 2023 International Congress

    A Novel Real Time Algorithm to Predict Freezing of Gait in Parkinson’s Patients Using Wearable Mobility Sensors Data

    N. Galor, T. Krasovsky, S. Hassin, B. Heimler, M. Plotnik (Ramat Gan, Israel)

    Objective: To develop an algorithm for real-time Freezing of gait (FOG) prediction based on the online monitoring of the stepping coherence. Background: FOG is a…
  • 2023 International Congress

    Montelukast as disease modifying treatment for Parkinson’s disease: a pilot study.

    J. Wallin, P. Svenningsson (Stockholm, Sweden)

    Objective: To assess safety and tolerability of high dose Montelukast as a possible disease modifying treatment for Parkinson’s disease. Background: Emerging evidence suggests that the…
  • 2023 International Congress

    Validation of the EQ-5D-3L in Spinocerebellar Ataxia (SCA)

    M. Buchholz, N. Weber, A. Rädke, J. Faber, T. Schmitz-Hübsch, H. Jacobi, F. Xie, T. Klockgether, B. Michalowsky (Greifswald, Germany)

    Objective: Our study aims to assess the acceptability, validity and responsiveness of the EQ-5D-3L in SCA types 1, 2, 3 and 6. Background: Although health-related…
  • 2023 International Congress

    Isolation of L1CAM-extracellular vesicles reveals signs of insulin resistance in Parkinson’s disease

    I. Markaki, W. Paslawski, T. Ntetsika, P. Svenningsson (Stockholm, Sweden)

    Objective: The aim of this study was to test the utility of isolating L1 Cell Adhesion Molecule (L1CAM)-derived extracellular vesicles (EVs) in quantification of glucose…
  • 2023 International Congress

    Impact of orthostatic hypotension with sleep disturbance on cognition

    A. Ovchynnykova, E. Trufanov (Kyiv, Ukraine)

    Objective: To define features of cognitive decline in a group of patients with orthostatic hypotension combined with sleep disorders. Background: recent data suggest that orthostatic…
  • 2023 International Congress

    LRRK2 G2019S mutation in Multiple System Atrophy, a case report

    T. Carrer, G. Bonato, M. Sandre, A. Emmi, A. Antonini (Padova, Italy)

    Objective: Presenting a case of Multiple System Atrophy (MSA) confirmed by skin biopsy with a peculiar genetic profile. Background: MSA is a rare neurodegenerative disorder characterized…
  • 2023 International Congress

    The role of structural changes in the retina and the vertical vestibulo-ocular reflex abnormality in gait disorders in Parkinson`s disease

    O. Alenikova, O. Davydova, N. Alenikov (Minsk, Belarus)

    Objective: Our goal was to investigate retinal structural changes as well as changes in visual cortex in PD patients with suppression deficiency of VOR and…
  • 2023 International Congress

    A 78-year-old man with progressive ataxia, palatal tremor, parkinsonism and motor neuron disease.

    P. Hoang, JR. Zuzuarregui (San Francisco, USA)

    Objective: To report a unique case of palatal tremor associated with parkinsonism, ataxia and motor neuron disease. Background: Progressive ataxia with palatal tremor (PAPT) is…
  • 2023 International Congress

    The neurological manifestations of PHARC syndrome: a systematic review

    V. Mendes Ferreira, M. Magriço, P. Bugalho, B. Meira, R. Barbosa (Lisboa, Portugal)

    Objective: To provide a systematic review of the neurological manifestations of the PHARC syndrome. Background: Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts (PHARC) syndrome…
  • « Previous Page
  • 1
  • …
  • 287
  • 288
  • 289
  • 290
  • 291
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley